These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 23828464)

  • 1. [Hypotensive effect of three different formulations of brimonidine tartrate in normal eyes].
    Abud TB; Scuoteguazza Filho M; Oliveira ES; Abud JF; Prata Junior JA
    Arq Bras Oftalmol; 2013; 76(2):69-71. PubMed ID: 23828464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of brimonidine 0.2% in controlling acute postoperative intraocular pressure elevation after phacoemulsification.
    Katsimpris JM; Siganos D; Konstas AG; Kozobolis V; Georgiadis N
    J Cataract Refract Surg; 2003 Dec; 29(12):2288-94. PubMed ID: 14709288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of brimonidine in preventing intraocular pressure spikes following phacoemulsification in glaucoma patients.
    Kandarakis A; Soumplis V; Karampelas M; Panos C; Kyriakos N; Baxevanakis A; Karagiannis D
    Eur J Ophthalmol; 2010; 20(6):994-9. PubMed ID: 20544673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the short-term hypotensive effects and side effects of unilateral brimonidine and apraclonidine in patients with elevated intraocular pressure.
    Yüksel N; Karabaş L; Altintaş O; Yildirim Y; Cağlar Y
    Ophthalmologica; 2002; 216(1):45-9. PubMed ID: 11901288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three-month comparison of brimonidine and latanoprost as adjunctive therapy in glaucoma and ocular hypertension patients uncontrolled on beta-blockers: tolerance and peak intraocular pressure lowering.
    Simmons ST; Earl ML;
    Ophthalmology; 2002 Feb; 109(2):307-14; discussion 314-5. PubMed ID: 11825814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brimonidine 0.15% versus apraclonidine 0.5% for prevention of intraocular pressure elevation after anterior segment laser surgery.
    Chen TC
    J Cataract Refract Surg; 2005 Sep; 31(9):1707-12. PubMed ID: 16246772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of brimonidine tartrate on retinal blood flow in patients with ocular hypertension.
    Carlsson AM; Chauhan BC; Lee AA; LeBlanc RP
    Am J Ophthalmol; 2000 Mar; 129(3):297-301. PubMed ID: 10704543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brimonidine 0.2% versus apraclonidine 0.5% for prevention of intraocular pressure elevations after anterior segment laser surgery.
    Chen TC; Ang RT; Grosskreutz CL; Pasquale LR; Fan JT
    Ophthalmology; 2001 Jun; 108(6):1033-8. PubMed ID: 11382625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Twelve-month results of an ongoing randomized trial comparing brimonidine tartrate 0.2% and timolol 0.5% given twice daily in patients with glaucoma or ocular hypertension. Brimonidine Study Group 2.
    LeBlanc RP
    Ophthalmology; 1998 Oct; 105(10):1960-7. PubMed ID: 9787370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brimonidine-purite 0.1% versus brimonidine-purite 0.15% twice daily in glaucoma or ocular hypertension: a 12-month randomized trial.
    Cantor LB; Safyan E; Liu CC; Batoosingh AL
    Curr Med Res Opin; 2008 Jul; 24(7):2035-43. PubMed ID: 18534052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypotensive efficacy of topical brimonidine for intraocular pressure spikes following intravitreal injections of antivascular endothelial growth factor agents: a randomised crossover trial.
    Felfeli T; Hostovsky A; Trussart R; Yan P; Brent MH; Mandelcorn ED
    Br J Ophthalmol; 2019 Oct; 103(10):1388-1394. PubMed ID: 30573499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Latanoprost and brimonidine: therapeutic and physiologic assessment before and after oral nonsteroidal anti-inflammatory therapy.
    Sponsel WE; Paris G; Trigo Y; Pena M; Weber A; Sanford K; McKinnon S
    Am J Ophthalmol; 2002 Jan; 133(1):11-8. PubMed ID: 11755835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brimonidine in the prevention of intraocular pressure elevation following argon laser trabeculoplasty.
    David R; Spaeth GL; Clevenger CE; Perell HF; Siegel LI; Henry JC; Stiles MC; Passo MS; Stamper RL; Walt JG
    Arch Ophthalmol; 1993 Oct; 111(10):1387-90. PubMed ID: 8105773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of topical brimonidine on intraocular pressure after small incision cataract surgery.
    Rainer G; Menapace R; Findl O; Petternel V; Kiss B; Georgopoulos M
    J Cataract Refract Surg; 2001 Aug; 27(8):1227-31. PubMed ID: 11524194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical experience with brimonidine 0.2% and timolol 0.5% in glaucoma and ocular hypertension.
    Schuman JS
    Surv Ophthalmol; 1996 Nov; 41 Suppl 1():S27-37. PubMed ID: 8970247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The safety and efficacy of unoprostone 0.15% versus brimonidine 0.2%.
    Stewart WC; Stewart JA; Day DG; Jenkins J
    Acta Ophthalmol Scand; 2004 Apr; 82(2):161-5. PubMed ID: 15043534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of brimonidine on aqueous humor dynamics in human eyes.
    Toris CB; Gleason ML; Camras CB; Yablonski ME
    Arch Ophthalmol; 1995 Dec; 113(12):1514-7. PubMed ID: 7487618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in intraocular pressure and ocular perfusion pressure after latanoprost 0.005% or brimonidine tartrate 0.2% in normal-tension glaucoma patients.
    Liu CJ; Ko YC; Cheng CY; Chiu AW; Chou JC; Hsu WM; Liu JH
    Ophthalmology; 2002 Dec; 109(12):2241-7. PubMed ID: 12466165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the safety and efficacy of twice daily brimonidine 0.2% versus betaxolol 0.25% in subjects with elevated intraocular pressure. The Brimonidine Study Group III.
    Serle JB
    Surv Ophthalmol; 1996 Nov; 41 Suppl 1():S39-47. PubMed ID: 8970248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, investigator-masked, 4-week study comparing timolol maleate 0.5%, brinzolamide 1%, and brimonidine tartrate 0.2% as adjunctive therapies to travoprost 0.004% in adults with primary open-angle glaucoma or ocular hypertension.
    Reis R; Queiroz CF; Santos LC; Avila MP; Magacho L
    Clin Ther; 2006 Apr; 28(4):552-9. PubMed ID: 16750466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.